Physiological and pathological factors of human breast disease that can influence optical diagnosis

Annals of the New York Academy of Sciences

Volumn 838, Issue , 1998, Pages 171-193

  Thomsen, Sharon ^a,c   Tatman, Dereck ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; BREAST DISEASE; CANCER DIAGNOSIS; CHROMATOPHORE; CONFERENCE PAPER; FEMALE; HUMAN; LIGHT SCATTERING; PATHOLOGY; PHYSIOLOGY;

EID: 0032498562     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb08197.x     Document Type: Conference Paper

References (79)

1. WELCH, A. J. & M. J. C. VAN GEMERT, eds. 1995. Optical-Thermal Response of Laser-Irradiated Tissue. 1-912. Plenum Press. New York.
2. HAMILTON, W. J. et al. 1972. Human Embryology, 4th edit. 1-646. Williams and Wilkins, Co. Baltimore.
3. MCCARTY, K. S., JR. & J. A. TUCKER. 1992. Breast. In Histology for Pathologists. S. S. Sternberg, Ed. 893-902. Raven Press, Ltd. New York.
4. PAGE, D. & T. J. ANDERSON. 1987. Diagnostic Histopathology of the Breast. 1-362. Churchill Livingstone. New York.
5. DRIFE, J. O. 1986. Breast development in puberty. Ann. N. Y. Acad. Sci. 464: 58-65.
6. BIRKENFELD, A. & N. G. KASE. 1994. Functional anatomy and physiology of the female breast. Obstet. Gynecol. Clin. North Am. 21: 433-444.
7. ROSEN, P. P. 1996. Breast Pathology. 1-978. Lippincott-Raven Press. Philadelphia.
8. PARKER, S. L. et al. 1997. Cancer statistics, 1997. CA 47: 5-65.
9. BRAVERMAN, I. M. 1989. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J. Invest. Dermatol. 93: 2S-9S.
10. MARCUS, R. & A. M. COULSTON. 1990. The vitamins, water-soluble vitamins & fat-soluble vitamins. In The Pharmacological Basis of Therapies. 8th. edit. A. G. Oilman et al., Eds. 1523-1571. Pergamon Press. New York.
11. NETTER, F. H. 1989. Atlas of Human Anatomy. Plates 167, 168 & 169. Ciba-Geigy, Inc. New Brunswick, N.J.
12. DRIFE, J. O. 1989. Breast modifications during the menstrual cycle. Int. J. Gynecol. Obstet. Suppl. 1: 19-24.
13. PETERS, V. G. et al. 1990. Optical properties of normal and diseased breast tissues in the visible and near-infrared. Phys. Med. Biol. 35: 1317-1334.
14. GHADIALLY, F. N. 1988. Ultrastructural Pathology of the Cell and Matrix. 3rd edit. Vols. 1 & 2. 1-1340. Butterworths. Boston.
15. BANCROFT, J. D. & A. STEVENS. 1996. Theory and Practice of Histological Techniques. 4th edit. 1-766. Churchill Livingston. New York.
16. THOMSEN, S. et al. 1990. Microscopic correlates of macroscopic optical property changes during thermal coagulation of myocardium. SPIE Proceedings. 1202: 2-11.
17. FLOCK, S. T. et al. 1987. Total attenuation coefficients and scattering phase functions of tissues and phantom materials at 633 nm. Med. Phys. 14: 835-841.
18. BOHREN, C. F. & D. R. HUFFMAN. 1983. Absorption and Scattering of Light by Small Particles. 1-519. John Wiley and Sons, Ltd. New York.
19. FAWCETT, D. W. 1993. Textbook of Histology. 1-964. Chapman and Hall. New York.
20. VAN DER REST, M. & R. GARBONE. 1991. Collagen family of proteins. FASEB J. 5: 2814-2823.
21. MONTES, G. S. et al. 1984. Collagen distribution in tissues. Ultrastructure of the Connective Tissue Matrix. 65-87. Martinus Nijhoff Pub. Boston.
22. UITTO, J. 1986. Connective tissue biochemistry of the aging dermis. Dermatol. Clin. 4: 433-446.
23. BURGESON, R. E. & M. NIMNI. 1992. Collagen types: molecular structure and tissue distribution. Clin. Orthop. Relat. Res. 282: 250-272.
24. SCOTT, J. E. 1991. Proteoglycan: collagen interactions in connective tissues: ultrastructural, biochemical, functional and evolutionary aspects. Int. J. Biol. Macromol. 13: 157-161.
25. THOMSEN, S. et al. 1989. Changes in birefringence as markers of thermal damage in tissues. IEEE Trans. BME 36: 1174-1179.
26. MAITLAND, D. J. & J. T. WALSH, JR. 1997. Quantitative measurements of linear birefringence during heating of native collagen. Lasers Surg. Med. 20: 310-318.
27. FISCHER, J. 1979. Ultrastructure of elastic fibers as shown by polarization optics after the topo-optical permanganate-bisulfite-toluidine blue reaction. Acta Histochem. 65: 87-98.
28. LIN, S-P. et al. 1997. Measurement of tissue optical properties using oblique incidence optical fiber reflectometry. Appl. Optics 36: 136-143.
29. OSTERMEYER, M. R. et al. 1996. Ncarfield polarization effects on light propagation in random media. In Proc. of Biomedical Optical Spectroscopy and Diagnostics, E. Sevick-Muraca & D. Benaron, Eds. 20-25. Optical Society of America. Washington, DC.
30. DUCK, F. A. 1990. Optical properties of tissue including ultraviolet and infrared radiation. In Physical Properties of Tissue. 43-71. Academic Press, Ltd. London.
31. GOODWIN, T. W. 1980. The Biochemistry of the Carotenoids. Vol. 1: 1-30. Chapman and Hall. London.
32. NICHOLS, B. L. & V. N. NICHOLS. 1979. Lactation. Adv. Pediatr. 26: 137-161.
33. RICHARDS-KORTUM, R. & E. SEVICK-MURACA. 1996. Quantitative optical spectroscopy for tissue diagnosis. Annu. Rev. Phys. Chem. 47: 555-606.
34. GOTTE, L. 1980. Molecular morphology of elastin. Front. Matrix Biol. 8: 33-53.
35. BLOMFIELD, J. & J. F. FARRAR. 1969. The fluorescent properties of maturing arterial elastin. Cardiovasc. Res. 3: 161-170.
36. THORNHILL, D. P. 1975. Separation of a series of chromophores and fluorophores present in elastin. Biochem. J. 147: 215-219.
37. HARTMANN, P. E. & C. G. PROSSER. 1984. Physiological basis of longitudinal changes in human milk yield and composition. Fed. Proc. 43: 2448-2453.
38. NEVILLE, M. C. 1990. The physiological basis of milk secretion. Ann. N. Y. Acad. Sci. 586: 1-11.
39. JENSEN, R. 1996. The lipids in human milk. Prog. Lipid Res. 35: 53-92.
40. WELCH, R. M. & J. W. A. Findlay. 1981. Excretion of drugs in human breast milk. Drug Metab. Rev. 12: 261-277.
41. WILSON, J. T. et al. 1980. Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin. Pharmacokinet. 5: 1-66.
42. COHEN, I. K. et al. 1992. Wound Healing: Biochemical and Clinical Aspects, 1-600. W. B. Saunders. Philadelphia.
43. COTRAN, R. et al. 1994. Inflammation and repair. Neoplasia. In Pathologic Basis of Disease. 5th edit. 51-92; 241-303. W. B. Saunders Co. Philadelphia.
44. RONNOV-JESSEN, L. et al. 1996. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76: 69-125.
45. FOLKMAN, J. 1992. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3: 65-71.
46. DUGAS, J. et al. 1986. Behavior of the refractive index and of the coefficient of thermal expansion of silicon with temperature. Appl. Optics 25: 3807-3808.
47. ROSENBERG, S. A. 1997. Principles of cancer management: biologic therapy. In Cancer: Principles and Practice of Oncology. 5th edit. V. T. DeVita, Jr. et al., Eds. Vol. 1: 349-373. Lippincott-Raven Publ. Philadelphia.
48. DVORAK, H. F. et al. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133: 95-109.
49. DVORAK, H. F. et al. 1991. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 3: 77-85.
50. SCHULTZ-HECTOR, S. et al. 1991. Vascular architecture of experimental tumors-influence of tumor volume and transplantation site. Int. J. Radiat. Biol. 60: 101-107.
51. WEIDNER, N. 1995. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat. 36: 169-180.
52. FREGENE, T. A. et al. 1994. Microvessel quantification as a measure of angiogenic activity in benign breast tissues lesions: a marker for precancerous disease? Int. J. Oncol. 4: 1199-1202.
53. OTTINETTI, A. & A. SAPINO. 1988. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res. Treat. 11: 241-248.
54. ESENALIEV, R. O. et al. 1997. Laser optoacoustic imaging for breast cancer diagnostics: limit of detection and comparison with X-ray and ultrasound imaging. SPIE Proc. 2979: in press.
55. PETRIER, C. et al. 1979. Studies on tetrapyrrol pigments - I. Absorption and fluorescence of biliverdin dimethyl esters of the IX series. Photochem. Photobiol. 29: 389-392.
56. MCDONAGH, A. F. 1979. In The Porphyrins. D. Dolphin, Ed. Vol. 6. Biochemistry Part A. 293-491. Academic Press. New York.
57. HEIRWEGH, K. R. M. et al. 1989. Chromatographic analysis and structure determination of biliverdins and bilirubins. J. Chromatogr. 496: 1-26.
58. HEIRWEGH, K. R. M. & S. BROWN. 1991. Bilirubin. 83. CRC Press. Boca Raton.
59. LAM. S. et al. 1990. Detection of early lung cancer using low dose photofrin II. Chest 97: 333-337.
60. KREIGMAIR, M. et al. 1996. Detection of early bladder cancer by 5-aminolevulinic acid-induced porphyrin fluorescence. J. Urol. 155: 105-110.
61. CUBEDDU, R. et al. 1993. Time-gated fluorescence imaging for the diagnosis of tumors in a murine model. Photochem. Photobiol. 57: 480-485.
62. PATHAK, I. et al. 1995. Detection of squamous neoplasia by fluorescence imaging comparing porfimer sodium fluorescence to tissue autofluorescence in the hamster cheek-pouch model. Am. J. Surg. 170: 423-426.
63. NAUTA, J. M. et al. 1997. In vivo photo-detection of chemically induced premalignant lesions and squamous cell carcinomas of the rat palatal mucosa. J. Photochem. Photobiol. B. Biol. Submitted.
64. TSAI, J. C. et al. 1993. Fluorospectral study of the rat brain and glioma in vivo. Lasers Surg. Med. 13: 321-331.
65. HENDERSON, B. & T. J. DOUGMERTY. 1992. Photodynamic Therapy: Basic Principles and Clinical Applications. 1-459. Marcel Dekker, Inc. New York.
66. LOH, C. S. et al. 1993. Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br. J. Cancer 68: 41-51.
67. WOLF, P. et al. 1993. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J. Am. Acad. Dermatol. 28: 17-22.
68. ADES, I. Z. 1990. Heme production in animal tissues: the regulation of biogenesis of δ-aminolevulinate synthase. Int. J. Biochem. 22: 565-578.
69. NILSSON, H. et al. 1994. Laser-induced fluorescence in malignant and normal tissue in mice injected with two different carotenoporphyrins. Br. J. Cancer 70: 873-879.
70. REDDI, E. et al. 1994. Carotenoporphyrins as selective photodiagnostic agents for tumours. Br. J. Cancer 69: 40-45.
71. DAVIDSON, R. S. & M. M. HICHENBACH. 1990. The use of fluorescent probes in immunochemistry. Photochem. Photobiol. 52: 431-438.
72. VAN LEENGOED, H. L. L. M. et al. 1991. Tumor tissue imaging using the localizing properties and fluorescence of some phthalocyanines. J. Radiat. Biol. 60: 121-124.
73. FINGER, V. H. et al. 1992. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res. 52: 4919-4921.
74. GROSSWEINER, L. I. 1994. The Science of Phototherapy. 47-49; 150-151. CRC Press. Boca Raton.
75. JAIN, R. K. 1991. Haemodynamic and transport barriers to the treatment of solid tumours. Int. J. Radiat. Biol. 60: 85-100.
76. LESS, J. R. et al. 1992. Interstitial hypertension in human breast and colorectal tumors. Cancer Res. 52: 6371-6374.
77. BOUCHER, Y. et al. 1996. Tumor angiogenesis and interstitial hypertension. Cancer Res. 56: 4264-4266.
78. NATHANSON, S. D. & L. NELSON. 1994. Interstitial fluid pressure in breast cancer, benign breast conditions and breast parenchyma. Ann. Surg. Oncol. 1: 333-338.
79. GREGORDIAS, G. 1995. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 13: 527-537.